Bradley Radoff and Jumana Capital disclosed a 7.6% position in Genesco Inc., the Nashville-based footwear and apparel retailer, marking the opening of an activist campaign targeting operational restructuring. The investment group filed their Schedule 13D with the SEC, signaling intent to push for strategic changes at a company with a market capitalization near $350 million.

Genesco operates 1,425 retail stores across the U.S. under banners including Journeys, Johnston & Murphy, and Schuh. The company reported $2.23 billion in revenue for fiscal 2024, down 3.2% year-over-year, while net income compressed to $48 million from $71 million the prior year. Same-store sales declined 4% in the most recent quarter, pressured by weakening mall traffic and inventory normalization after pandemic-era stockpiling. Radoff, who previously ran activist campaigns at smaller retail targets, typically focuses on balance sheet optimization and board refreshment at companies trading below 0.4x sales.

The timing matters because Genesco's operating margin contracted 180 basis points to 5.1% over the past twelve months, while inventory turns slowed to 2.8x from 3.1x two years prior. The company carries $140 million in net debt, manageable but restrictive given free cash flow of only $52 million last fiscal year. Radoff and Jumana likely see room to rationalize the store footprint—Genesco still operates 247 underperforming locations flagged in internal reviews—and potentially separate the higher-margin Johnston & Murphy direct-to-consumer business, which generates 14% operating margins versus 3% for the wholesale segment. Activist interest in mid-cap retail has intensified as private equity firms step back from leveraged buyouts in the sector, leaving public market pressure as the primary catalyst for operational tightening.

Allocators should watch for a formal activist letter within 30 days, likely demanding board seats and a formal strategic review. Genesco's annual meeting is scheduled for late June, giving the group four months to build proxy support if management resists. The company's largest institutional holder, Dimensional Fund Advisors with 9.2%, has historically supported governance changes at similar-sized retailers. Genesco shares trade at 0.16x sales and 6.8x forward earnings, a 35% discount to the specialty retail peer group, suggesting the market already prices in structural headwinds but may undervalue the probability of forced restructuring.

Radoff's prior campaigns at companies under $500 million market cap resulted in asset sales or board turnover within eight months on average. Genesco now trades at $24.80, up 8.3% on the disclosure, with options activity showing a 40% spike in January 2026 call volume at the $30 strike.